DNTH compared with CGON: revenue, margins and what each company keeps, and the suppliers and customers both name

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

CGONCG Oncology, Inc.

Mkt capRevenueRevenue

Compare

DNTHDianthus Therapeutics, Inc.

CGONCG Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DNTH 3

—Nanjing Leads Biolabsunlistedsupplier

—IONTASunlistedsupplier

—Tenacia Biotechnology (Hong Kong)unlistedcustomer

Shared 0

No disclosed counterparties: CGON.

Only CGON 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

DNTHDianthus Therapeutics, Inc.

82.32▼−0.08%· post 82.32· delayed

Mkt cap$4.6BRevenue$761,000Q2 FY26Revenue$6MFY24

CGONCG Oncology, Inc.

62.03▼−4.10%· post 62.03· delayed

After hoursNov 2 '26delayed

Mkt cap$5.7BRevenue$1MQ2 FY26Revenue—

Compare

After hoursNov 2 '26delayed

DNTHDianthus Therapeutics, Inc.

CGONCG Oncology, Inc.

82.32▼−0.08%post 82.32delayed

Price

62.03▼−4.10%post 62.03delayed

$4.6B

Mkt cap

$5.7B

Q2 FY26$761,000

Revenue

$1MQ2 FY26

FY24$6M

Revenue

—

DNTH82.32▼−0.08%vsCGON62.03▼−4.10%After hoursNov 2 '26delayed